ASPIRE Webinar - Darin Ingels, ND Low Dose Immunotherapy: A Novel Treatment for PANS

ASPIRE PANS PANDAS Integrative Treatment webinar series

Lecturer: Darin Ingels, ND
Webinar: Low Dose Immunotherapy: A Novel Treatment for PANS
Main Webinar link: https://aspire.care/videos/webinar-da...

Abstract: It is well established that certain infectious diseases can be underlying triggers for PANS and that the presence of infection is not the only mechanism by which neural inflammation occurs. The capacity for any microbe to induce autoantibodies against the brain or nerves exists and current research has shown that any number of various bacteria, viruses, fungi and parasites can modulate the immune system in a negative way leading to inflammation in the brain and ultimately PANS. While conventional therapy has mostly targeted eradication of the organism, immune suppressive therapy or IVIG, there are few options that work to modulate the immune system and downregulate this autoimmune response. Low dose immunotherapy (LDI) was developed by Dr. Ty Vincent as a way to help counter the effects of microbe-induced autoimmunity. Through an immune concept called molecular mimicry, our immune system can accidentally start attacking out own tissues if there is a molecule on the microbe that is structurally similar to something that is part of us. In an effort to eradicate the organism, these antibodies bind to our own tissues, causing inflammation and destruction. LDI works to offset this reaction and reestablish a healthy balance in the immune system. In this lecture, Dr. Ingels will review how LDI works and will share his clinical experience in using it in his patients. He will also discuss the nuances of this therapy and how it can be integrated into a comprehensive approach to treating PANS.



ASPIRE Links
Download ASPIRE’s PANS PANDAS Diagnosis and Treatment – Resources for Clinicians: https://aspire.care/clinicians/aspire...

Download ASPIRE’s Overview of PANS PANDAS Toolkit: https://aspire.care/clinicians/aspire...
For more information on ASPIRE’s Webinar Series: https://aspire.care/resources/aspire-...
Subscribe to the ASPIRE Newsletter! - https://aspire.salsalabs.org/newslett...

ABOUT ASPIRE
Our Mission - To improve the lives of children and adults affected by PANS, PANDAS, and related encephalopathies.
Our Vision - We aspire to create a world where children and adults affected by PANS, PANDAS and related encephalopathies obtain a timely diagnosis from informed providers and receive effective, proven and affordable treatments and support in all areas of daily living, without discrimination.
Who We Are - We are experienced leaders in the PANS advocacy community. We are parents, providers and experts in our field who believe collaboration and empowered action are the keys to the world we seek: one where no one suffers through PANS and immune-related encephalopathies without access to a knowledgeable provider, insurance coverage for standard-of-care treatments or the support that comes with public awareness.